Breakdown of non immune metastasis resistance after cytostatic drugs

conference paper



Ruiter, J. de

Smink, T.

Jansen, J.

Putten, L.M. van
It can be concluded in this study that Cyclophosphamide decreases a nonimmunological resistance against the lodging and growth of any type of cell in the lung.
Chemicals/CAS: bleomycin, 11056-06-7; cyclophosphamide, 50-18-0; fluorouracil, 51-21-8; heparin, 37187-54-5, 8057-48-5, 8065-01-8, 9005-48-5; methotrexate, 15475-56-6, 59-05-2, 7413-34-5
Topics














bleomycincyclophosphamidefluorouracilheparinmethotrexatecancer chemotherapycancer immunologycorynebacterium parvumdrug resistanceimmune responselung metastasismajor clinical studymetastasisosteosarcomatherapy
TNO Identifier
228122
Repository link
https://resolver.tno.nl/uuid:7522f2cc-d153-4e15-aa27-0870c3bb872b
Publisher
Plenum
Source title
Chemotherapy, Proceedings of the 9th International Congress of Chemotherapy
Place of publication
New York
Pages
9-10
Files
To receive the publication files, please send an e-mail request to TNO Repository.